Posted On: June 10, 2026
If you have heard the words “GLP-1” or “Ozempic” lately and wondered what they actually mean for your health, you are not alone. These medications have moved from specialty clinics into the mainstream conversation, and with good reason. But beneath the headlines and social media posts, there is a deeper story worth understanding: the story of metabolic health.
In this post, I want to walk you through what metabolic health actually means, what GLP-1 medications are and are not, and what you can do today to protect yourself. Whether you are already on one of these medications, considering them, or simply trying to understand your own risk, this conversation matters. Let us start at the beginning.
Metabolic health refers to how well your body processes and uses energy. When your metabolism works properly, your blood sugar stays stable, your blood pressure stays in range, your cholesterol profile looks good, and your body maintains a healthy weight. When things go wrong in any of these areas, your risk for serious disease climbs.
Metabolic syndrome is the clinical term for having several of these problems at once. Doctors diagnose it when you have three or more of the following:1
Here is the part that surprises most people: approximately 38.7% of U.S. adults meet the criteria for metabolic syndrome, according to the most recent NHANES data from 2013–2023.2 That is still roughly 1 in 3 American adults, and many of them do not know it. The condition often develops quietly, without obvious symptoms, for years before it leads to something more serious.
Untreated metabolic syndrome raises your risk for type 2 diabetes, cardiovascular disease, fatty liver disease, and certain cancers. Obesity plays a key role in this picture, but it is not the whole story. Obesity is a complex condition shaped by genetics, hormones, metabolism, environment, and behavior. That is why willpower alone is rarely the answer and why medicine has evolved to offer more targeted support.
GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally releases after you eat. It signals your pancreas to produce insulin, tells your brain you are full, and slows the movement of food through your stomach. GLP-1 receptor agonist medications mimic this hormone, turning up signals your body already uses to regulate hunger, blood sugar, and digestion.
The two major types most people encounter right now are:
Semaglutide currently carries FDA approval for type 2 diabetes management, chronic weight management in adults with obesity or overweight with a weight-related condition, and, more recently, cardiovascular risk reduction in adults with cardiovascular disease and obesity. Tirzepatide holds similar approvals. Both have also received FDA clearance for the treatment of obstructive sleep apnea in adults with obesity.
Clinical trials show these medications do more than reduce weight. The trials found that tirzepatide reduced the severity of sleep apnea events by up to 63% in participants with obesity.3 An international clinical trial demonstrated that semaglutide cut the risk of major cardiovascular events by 20% in people who were overweight or obese and had established cardiovascular disease.4 Research also points to kidney protection and improvements in heart failure outcomes.
These medications are not a shortcut, a replacement for healthy habits, or a one-size solution. They work best when paired with sustainable nutrition, physical activity, and regular medical oversight. They are also not appropriate for everyone, including those with a personal or family history of certain thyroid cancers, pancreatitis, or other specific conditions should not take them.
One more thing worth saying directly: compounded versions of these medications, often sold online without a prescription, present real risks. Dosing, purity, and quality vary significantly outside of regulated pharmaceutical channels. If you are considering these medications, please work with a physician who can evaluate your full health picture and monitor you appropriately.
The most common side effects are gastrointestinal: nausea, constipation, reflux, and occasionally vomiting. These tend to be most pronounced in the early weeks and usually improve as your body adjusts. Starting at a low dose and increasing slowly helps most people manage this well.
Less common but serious risks include pancreatitis and gallbladder disease. Anyone with a relevant personal or family history needs to discuss these risks with their doctor before starting.
Two areas researchers actively study are muscle and bone mass loss during rapid weight loss and long-term safety. When weight drops quickly, some loss of lean muscle is expected, but too much muscle loss can slow your metabolism, reduce physical strength and function, and compromise bone density. This is why strength training and adequate protein intake matter so much during treatment. On long-term safety, the data look reassuring so far, but these medications are relatively new at the population scale, and ongoing monitoring is appropriate. Research also shows that many people regain weight after stopping, which raises real questions about the duration of treatment and the need for individualized planning.
GLP-1 medications are powerful tools, but they work alongside good habits, not instead of them. The foundation of metabolic health has not changed.
A Mediterranean-style diet, rich in vegetables, legumes, whole grains, healthy fats, and lean protein, consistently shows benefit for metabolic health, cardiovascular risk, and inflammation. During weight loss on a GLP-1, protein adequacy becomes especially important to protect muscle mass. Most adults benefit from aiming for around 1.5 grams of protein per kilogram of ideal body weight daily.5
Resistance exercise preserves lean muscle during weight loss and improves insulin sensitivity. Even two sessions per week make a meaningful difference. If you are on a GLP-1, strength training is not optional; it is part of protecting the quality of the weight you lose.
Poor sleep and chronic stress can worsen insulin resistance and make appetite harder to manage. They should be treated as part of the plan, not an afterthought. Aim for seven to nine hours of quality sleep, keep a steady bedtime when possible, and find ways to manage stress during the day, such as walking, stretching, breathing exercises, or taking a break from screens. Alcohol, worth mentioning separately, disrupts sleep quality, raises triglycerides, and adds metabolically empty calories.
Women face a distinct and often underappreciated metabolic shift as they move through perimenopause and menopause. Estrogen plays a significant role in insulin sensitivity, fat distribution, and lipid metabolism. As estrogen levels decline, many women notice changes in body composition, specifically more abdominal fat, even without significant changes in weight or diet.
Certain hormonal conditions also affect metabolic health in women at any age. Thyroid dysfunction, polycystic ovary syndrome, or PCOS, and adrenal imbalances can all drive insulin resistance, weight gain, and abnormal lipid profiles. A thorough metabolic evaluation in women includes assessing these hormonal factors alongside standard metabolic markers.
Emerging research suggests that combining GLP-1 medications with hormone replacement therapy (HRT) produces greater weight loss in postmenopausal women than either treatment alone.6 The findings are promising, but this is still an active area of study, and more research is needed before firm conclusions can be made. If you are postmenopausal and considering a GLP-1, a conversation about HRT may belong in the same discussion.
The bottom line for women: your metabolic health does not exist in a hormone vacuum. An evaluation that looks at both metabolic and hormonal factors together gives you a far more complete picture.
You cannot manage what you do not measure. At your annual exam, ask about the following:
You should not have to request most of these tests separately. They should be part of a routine annual exam or baseline metabolic screening. The goal is not only to know your numbers today, but to track them over time, see whether they are moving in the right direction, and catch concerning changes early.
More than half of adults with prediabetes remain undiagnosed,7 making the case for proactive screening at annual visits rather than waiting for symptoms to appear. Knowing your numbers is the single most actionable step you can take today.
Consider having this conversation if any of the following apply to you:
Social media and telehealth shortcuts are not a substitute for personalized medical guidance. The same medication at the same dose does not produce the same outcome in every person. Your genetics, your hormonal status, your other health conditions, and your lifestyle all shape how you respond to treatment.
At Eileen West, MD and Associates, a comprehensive metabolic evaluation is part of every annual member exam. That means we look at cardiovascular risk, metabolic markers, and hormonal health together, not in separate silos. If something is off, we find it early. If you are a candidate for a GLP-1 medication, we discuss it in the context of your full picture, not as a standalone prescription.
Yes, it can be. Many people improve or even reverse the warning signs with better nutrition, regular movement, better sleep, weight loss when needed, and medication when appropriate. The sooner you address it, the better your chances of lowering your future risk.
Not always, but GLP-1 medications are not for everyone. Right now, doctors most often prescribe them for people with type 2 diabetes, obesity, or certain metabolic health risks. The best way to know if one makes sense for you is to review your labs, weight history, heart risk, and overall health with your doctor.
During perimenopause and menopause, lower estrogen can affect how your body handles blood sugar, cholesterol, and belly fat. Some women notice their waist size, triglycerides, or blood sugar rise even if their weight does not change much. This is a good time to talk with your doctor about the right plan, including whether hormone therapy may fit your situation.
Start with the basics: fasting blood sugar (in CMP), A1C, a cholesterol panel, blood pressure, and waist measurement. ApoB can also give a clearer look at heart risk when available. For women, thyroid testing and hormone testing may also help, especially if you have symptoms or changes after 40.
For many patients, the safety data looks encouraging, but these medications still need medical follow-up. Some people have side effects, and not everyone should take them. Because weight often returns after stopping, many patients may need a long-term plan with regular checkups, lab work, nutrition support, and strength training.
Metabolic health sits at the center of some of the most serious threats to long-term wellness: heart disease, type 2 diabetes, cognitive decline, and cancer. GLP-1 medications represent a genuine advance in our ability to address these risks, especially for people who have struggled despite consistent effort. But they are tools, not magic.
Whether or not a GLP-1 is right for you, the foundations apply to everyone. Know your numbers. Address risk early. Work with a doctor who sees the full picture, not just one piece of it.
Leading the way in women's healthcare is renowned board-certified internal medicine doctor Dr. Eileen West. She has over 20 years of experience and is recognized for her expertise in menopause, osteoporosis, and cardiovascular disease prevention. Her excellence-driven compassionate approach, which is associated with the American College of Physicians, improves the lives of her patients by putting a strong emphasis on their overall well-being.
Location: Fairfax, Virginia
Areas of Expertise: Women's Health, Menopause Management, Cardiovascular Disease Prevention, Osteoporosis Diagnosis and Treatment.
Join our Email Newsletter to get the latest and greatest tips on ways to maximize your health, invitations to educational events, and other practice news!
By submitting this form, you are consenting to receive marketing emails from Eileen West, MD and Associates.
